Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)

Status unconfirmed · Phase 2

Conditions studied: Tuberculosis Infection

In brief

Dose comparison study of tuberculin purified protein derivative (PPD)Aplisol with the standard tuberculin purified derivative (PPD-S2).

Key facts

Study ID
NCT01689831
Run by
JHP Pharmaceuticals LLC
People needed
168
Starts
2012-05-01
Expected to finish
2012-12-01
Last updated by the study team
2012-09-21

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.